Global Drug Discovery Informatics Market 2019 Growth, COVID Impact, Trends Analysis Report 2025

The growing technological advancement such as microarray-based expression profiling in genomics, proteomics and drug discovery domains, create a large amount of biological data that further encourages the demand of drug discovery informatics solutions. The drug discovery informatics solutions provide clinical decision systems that support R&D programs and other research studies to discover and develop safe and effective drugs for various chronic diseases including cancer, diabetes, and neurological diseases, among others. R&D budget has been increased around the globe owing to increasing funding, grants and other government support in R&D for drug discovery. The increase in R&D expenditure is also driven by increasing pharmaceutical sales coupled with technological advancement.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/drug-discovery-informatics-market

A significant increase in government funding for R&D programs has boosted the drug discovery market and other associated markets such as drug discovery informatics market. In 2018, it was stated by the NIH (National Institutes of Health), one of the foremost medical research centers, globally, that it invests around $39 billion for medical research in the US annually. Over 80% of the organization’s funding is granted through around 50,000 competitive grants to over 300,000 researchers at research institutions, medical schools, and universities across the US and other economies. Numerous investments in the industry have inspired significant financial resources into drug discovery space, enabling healthcare companies and organizations the opportunity of investing in R&D programs for various drug discovery and treatments coupled with adopting digital technologies such as informatics tools.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/drug-discovery-informatics-market

Growth in emerging economies will spur the drug discovery informatics market
The emerging ASEAN economies such as Singapore, Philippines, and Indonesia among others are full of opportunities and are getting an overwhelming response to drug discovery informatics services. Technological advancement and innovation in drug discovery informatics services and solutions are attracting the Lifescience companies, pharma companies, and other healthcare providers to adopt these products extensively. Growing ASEAN economies are the key destinations for informatics solutions and services providers to grow significantly due to the presence of a huge targeted customer base and improving the healthcare system. Additionally, with the effect of favorable regulations and government support various healthcare and cloud market players are entering the ASEAN region for business expansion or funding the regional players to explore the market opportunities.

In recent years, the trend for CROs is increasing in large and small biopharmaceutical companies for research services, across the breadth of manufacturing and R&D operations. CROs provide support to the biotechnology, pharmaceutical, and medical device industries through outsourced R&D services that span preclinical research, drug discovery, clinical research, commercialization, clinical trial management, and pharmacovigilance. Whilst the pharmaceutical industry is evolving, the biotechnology and pharmaceutical companies are noticeably dedicating their resources to particular areas of the healthcare industry’s value chain and have significantly developed vendor relationships for non-core functions. This trend has significantly benefitted the CROs by capturing a growing share of the core and non-core functions that optimally large pharmaceutical companies seek to outsource.

Global drug discovery informatics Market Segmentation
By Function
• Docking
• Molecular Modeling
• Libraries and Database Preparation
• Sequencing and Target Data Analysis
• Others
By End-User
• Pharmaceutical & Biotechnology Companies
• Contract Research Organization(CRO)
• Others( Research Institutes)

Global drug discovery informatics Market – Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World

Company Profiles
• Accenture PLC
• Albany Molecular Research Inc.
• Charles River Laboratories, Inc.
• ChemBridge Corp.
• Clarivate Analytics
• Certara, L.P.
• Cognizant Function Solutions Corp.
• Collaborative Drug Discovery Inc.
• Dassault Systèmes SE
• Eurofins GSC Lux SARL
• Evotec SE
• GVK Biosciences Pvt Ltd.
• Jubilant Life Sciences
• Infosys Limited
• IBM Corp.
• Novo Informatics Pvt. Ltd.
• OpenEye Scientific Software
• PerkinElmer Inc.
• Schrödinger, LLC
• Selvita S.A.

Reasons to Buying From us –
• We cover more than 15 major industries, further segmented into more than 90 sectors.
• More than 120 countries are for analysis.
• Over 100+ paid data sources mined for investigation.
• Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/drug-discovery-informatics-market

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.